The global market for Genetic Testing For Neurological Disorders was valued at US$ 2835 million in the year 2024 and is projected to reach a revised size of US$ 5631 million by 2031, growing at a CAGR of 10.3% during the forecast period.

Genetic Testing For Neurological Disorders Market

Genetic testing for neurological diseases uses technologies such as gene sequencing to analyze pathogenic variants related to the nervous system in the patient's DNA. It is used to confirm the molecular causes of diseases such as hereditary epilepsy, leukodystrophy, motor neuron disease, and assist in clinical diagnosis, prognosis assessment, and family genetic counseling.

North American market for Genetic Testing For Neurological Disorders is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Genetic Testing For Neurological Disorders is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Genetic Testing For Neurological Disorders in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Genetic Testing For Neurological Disorders include Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, Quest Diagnostics, MedGenome Labs, GeneDx, Connecticut Children's, Labcorp (Invitae/MNG Laboratories), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genetic Testing For Neurological Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Testing For Neurological Disorders.

The Genetic Testing For Neurological Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Testing For Neurological Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Testing For Neurological Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genetic Testing For Neurological Disorders Market Report

Report Metric	Details
Report Name	Genetic Testing For Neurological Disorders Market
Accounted market size in year	US$ 2835 million
Forecasted market size in 2031	US$ 5631 million
CAGR	10.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Exome Sequencing Whole Genome Sequencing RNA Sequencing General DNA Testing
Segment by Application	Hospitals Specialty Clinics Diagnostics Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, Quest Diagnostics, MedGenome Labs, GeneDx, Connecticut Children's, Labcorp (Invitae/MNG Laboratories)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Testing For Neurological Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Genetic Testing For Neurological Disorders Market growing?

Ans: The Genetic Testing For Neurological Disorders Market witnessing a CAGR of 10.3% during the forecast period 2025-2031.

What is the Genetic Testing For Neurological Disorders Market size in 2031?

Ans: The Genetic Testing For Neurological Disorders Market size in 2031 will be US$ 5631 million.

Who are the main players in the Genetic Testing For Neurological Disorders Market report?

Ans: The main players in the Genetic Testing For Neurological Disorders Market are Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, Quest Diagnostics, MedGenome Labs, GeneDx, Connecticut Children's, Labcorp (Invitae/MNG Laboratories)

What are the Application segmentation covered in the Genetic Testing For Neurological Disorders Market report?

Ans: The Applications covered in the Genetic Testing For Neurological Disorders Market report are Hospitals, Specialty Clinics, Diagnostics Laboratories

What are the Type segmentation covered in the Genetic Testing For Neurological Disorders Market report?

Ans: The Types covered in the Genetic Testing For Neurological Disorders Market report are Exome Sequencing, Whole Genome Sequencing, RNA Sequencing, General DNA Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Exome Sequencing

1.2.3 Whole Genome Sequencing

1.2.4 RNA Sequencing

1.2.5 General DNA Testing

1.3 Market by Application

1.3.1 Global Genetic Testing For Neurological Disorders Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Diagnostics Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Testing For Neurological Disorders Market Perspective (2020-2031)

2.2 Global Genetic Testing For Neurological Disorders Growth Trends by Region

2.2.1 Global Genetic Testing For Neurological Disorders Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genetic Testing For Neurological Disorders Historic Market Size by Region (2020-2025)

2.2.3 Genetic Testing For Neurological Disorders Forecasted Market Size by Region (2026-2031)

2.3 Genetic Testing For Neurological Disorders Market Dynamics

2.3.1 Genetic Testing For Neurological Disorders Industry Trends

2.3.2 Genetic Testing For Neurological Disorders Market Drivers

2.3.3 Genetic Testing For Neurological Disorders Market Challenges

2.3.4 Genetic Testing For Neurological Disorders Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genetic Testing For Neurological Disorders Players by Revenue

3.1.1 Global Top Genetic Testing For Neurological Disorders Players by Revenue (2020-2025)

3.1.2 Global Genetic Testing For Neurological Disorders Revenue Market Share by Players (2020-2025)

3.2 Global Top Genetic Testing For Neurological Disorders Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genetic Testing For Neurological Disorders Revenue

3.4 Global Genetic Testing For Neurological Disorders Market Concentration Ratio

3.4.1 Global Genetic Testing For Neurological Disorders Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genetic Testing For Neurological Disorders Revenue in 2024

3.5 Global Key Players of Genetic Testing For Neurological Disorders Head office and Area Served

3.6 Global Key Players of Genetic Testing For Neurological Disorders, Product and Application

3.7 Global Key Players of Genetic Testing For Neurological Disorders, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Testing For Neurological Disorders Breakdown Data by Type

4.1 Global Genetic Testing For Neurological Disorders Historic Market Size by Type (2020-2025)

4.2 Global Genetic Testing For Neurological Disorders Forecasted Market Size by Type (2026-2031)

5 Genetic Testing For Neurological Disorders Breakdown Data by Application

5.1 Global Genetic Testing For Neurological Disorders Historic Market Size by Application (2020-2025)

5.2 Global Genetic Testing For Neurological Disorders Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genetic Testing For Neurological Disorders Market Size (2020-2031)

6.2 North America Genetic Testing For Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025)

6.4 North America Genetic Testing For Neurological Disorders Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genetic Testing For Neurological Disorders Market Size (2020-2031)

7.2 Europe Genetic Testing For Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genetic Testing For Neurological Disorders Market Size by Country (2020-2025)

7.4 Europe Genetic Testing For Neurological Disorders Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Genetic Testing For Neurological Disorders Market Size (2020-2031)

8.2 Asia-Pacific Genetic Testing For Neurological Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genetic Testing For Neurological Disorders Market Size by Region (2020-2025)

8.4 Asia-Pacific Genetic Testing For Neurological Disorders Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Genetic Testing For Neurological Disorders Market Size (2020-2031)

9.2 Latin America Genetic Testing For Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025)

9.4 Latin America Genetic Testing For Neurological Disorders Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genetic Testing For Neurological Disorders Market Size (2020-2031)

10.2 Middle East & Africa Genetic Testing For Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2020-2025)

10.4 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Genetic Testing For Neurological Disorders Introduction

11.1.4 Illumina Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 CENTOGENE

11.2.1 CENTOGENE Company Details

11.2.2 CENTOGENE Business Overview

11.2.3 CENTOGENE Genetic Testing For Neurological Disorders Introduction

11.2.4 CENTOGENE Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.2.5 CENTOGENE Recent Development

11.3 Victorian Clinical Genetics Services

11.3.1 Victorian Clinical Genetics Services Company Details

11.3.2 Victorian Clinical Genetics Services Business Overview

11.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Introduction

11.3.4 Victorian Clinical Genetics Services Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.3.5 Victorian Clinical Genetics Services Recent Development

11.4 PacBio

11.4.1 PacBio Company Details

11.4.2 PacBio Business Overview

11.4.3 PacBio Genetic Testing For Neurological Disorders Introduction

11.4.4 PacBio Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.4.5 PacBio Recent Development

11.5 Mayo Clinic

11.5.1 Mayo Clinic Company Details

11.5.2 Mayo Clinic Business Overview

11.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Introduction

11.5.4 Mayo Clinic Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.5.5 Mayo Clinic Recent Development

11.6 Quest Diagnostics

11.6.1 Quest Diagnostics Company Details

11.6.2 Quest Diagnostics Business Overview

11.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Introduction

11.6.4 Quest Diagnostics Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.6.5 Quest Diagnostics Recent Development

11.7 MedGenome Labs

11.7.1 MedGenome Labs Company Details

11.7.2 MedGenome Labs Business Overview

11.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Introduction

11.7.4 MedGenome Labs Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.7.5 MedGenome Labs Recent Development

11.8 GeneDx

11.8.1 GeneDx Company Details

11.8.2 GeneDx Business Overview

11.8.3 GeneDx Genetic Testing For Neurological Disorders Introduction

11.8.4 GeneDx Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.8.5 GeneDx Recent Development

11.9 Connecticut Children's

11.9.1 Connecticut Children's Company Details

11.9.2 Connecticut Children's Business Overview

11.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Introduction

11.9.4 Connecticut Children's Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.9.5 Connecticut Children's Recent Development

11.10 Labcorp (Invitae/MNG Laboratories)

11.10.1 Labcorp (Invitae/MNG Laboratories) Company Details

11.10.2 Labcorp (Invitae/MNG Laboratories) Business Overview

11.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Introduction

11.10.4 Labcorp (Invitae/MNG Laboratories) Revenue in Genetic Testing For Neurological Disorders Business (2020-2025)

11.10.5 Labcorp (Invitae/MNG Laboratories) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Illumina Inc

CENTOGENE

Victorian Clinical Genetics Services

Connecticut Children's

Labcorp (Invitae/MNG Laboratories)

List of Tables

Table 1. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Exome Sequencing

Table 3. Key Players of Whole Genome Sequencing

Table 4. Key Players of RNA Sequencing

Table 5. Key Players of General DNA Testing

Table 6. Global Genetic Testing For Neurological Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Genetic Testing For Neurological Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Genetic Testing For Neurological Disorders Market Share by Region (2020-2025)

Table 10. Global Genetic Testing For Neurological Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Genetic Testing For Neurological Disorders Market Share by Region (2026-2031)

Table 12. Genetic Testing For Neurological Disorders Market Trends

Table 13. Genetic Testing For Neurological Disorders Market Drivers

Table 14. Genetic Testing For Neurological Disorders Market Challenges

Table 15. Genetic Testing For Neurological Disorders Market Restraints

Table 16. Global Genetic Testing For Neurological Disorders Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Genetic Testing For Neurological Disorders Market Share by Players (2020-2025)

Table 18. Global Top Genetic Testing For Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Testing For Neurological Disorders as of 2024)

Table 19. Ranking of Global Top Genetic Testing For Neurological Disorders Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Genetic Testing For Neurological Disorders Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Genetic Testing For Neurological Disorders, Headquarters and Area Served

Table 22. Global Key Players of Genetic Testing For Neurological Disorders, Product and Application

Table 23. Global Key Players of Genetic Testing For Neurological Disorders, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Genetic Testing For Neurological Disorders Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Genetic Testing For Neurological Disorders Revenue Market Share by Type (2020-2025)

Table 27. Global Genetic Testing For Neurological Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Genetic Testing For Neurological Disorders Revenue Market Share by Type (2026-2031)

Table 29. Global Genetic Testing For Neurological Disorders Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Genetic Testing For Neurological Disorders Revenue Market Share by Application (2020-2025)

Table 31. Global Genetic Testing For Neurological Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Genetic Testing For Neurological Disorders Revenue Market Share by Application (2026-2031)

Table 33. North America Genetic Testing For Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Genetic Testing For Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Genetic Testing For Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Genetic Testing For Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Genetic Testing For Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Genetic Testing For Neurological Disorders Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Genetic Testing For Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Genetic Testing For Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 48. Illumina Company Details

Table 49. Illumina Business Overview

Table 50. Illumina Genetic Testing For Neurological Disorders Product

Table 51. Illumina Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 52. Illumina Recent Development

Table 53. CENTOGENE Company Details

Table 54. CENTOGENE Business Overview

Table 55. CENTOGENE Genetic Testing For Neurological Disorders Product

Table 56. CENTOGENE Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 57. CENTOGENE Recent Development

Table 58. Victorian Clinical Genetics Services Company Details

Table 59. Victorian Clinical Genetics Services Business Overview

Table 60. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product

Table 61. Victorian Clinical Genetics Services Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 62. Victorian Clinical Genetics Services Recent Development

Table 63. PacBio Company Details

Table 64. PacBio Business Overview

Table 65. PacBio Genetic Testing For Neurological Disorders Product

Table 66. PacBio Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 67. PacBio Recent Development

Table 68. Mayo Clinic Company Details

Table 69. Mayo Clinic Business Overview

Table 70. Mayo Clinic Genetic Testing For Neurological Disorders Product

Table 71. Mayo Clinic Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 72. Mayo Clinic Recent Development

Table 73. Quest Diagnostics Company Details

Table 74. Quest Diagnostics Business Overview

Table 75. Quest Diagnostics Genetic Testing For Neurological Disorders Product

Table 76. Quest Diagnostics Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 77. Quest Diagnostics Recent Development

Table 78. MedGenome Labs Company Details

Table 79. MedGenome Labs Business Overview

Table 80. MedGenome Labs Genetic Testing For Neurological Disorders Product

Table 81. MedGenome Labs Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 82. MedGenome Labs Recent Development

Table 83. GeneDx Company Details

Table 84. GeneDx Business Overview

Table 85. GeneDx Genetic Testing For Neurological Disorders Product

Table 86. GeneDx Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 87. GeneDx Recent Development

Table 88. Connecticut Children's Company Details

Table 89. Connecticut Children's Business Overview

Table 90. Connecticut Children's Genetic Testing For Neurological Disorders Product

Table 91. Connecticut Children's Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 92. Connecticut Children's Recent Development

Table 93. Labcorp (Invitae/MNG Laboratories) Company Details

Table 94. Labcorp (Invitae/MNG Laboratories) Business Overview

Table 95. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product

Table 96. Labcorp (Invitae/MNG Laboratories) Revenue in Genetic Testing For Neurological Disorders Business (2020-2025) & (US$ Million)

Table 97. Labcorp (Invitae/MNG Laboratories) Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Genetic Testing For Neurological Disorders Picture

Figure 2. Global Genetic Testing For Neurological Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genetic Testing For Neurological Disorders Market Share by Type: 2024 VS 2031

Figure 4. Exome Sequencing Features

Figure 5. Whole Genome Sequencing Features

Figure 6. RNA Sequencing Features

Figure 7. General DNA Testing Features

Figure 8. Global Genetic Testing For Neurological Disorders Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Genetic Testing For Neurological Disorders Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Specialty Clinics Case Studies

Figure 12. Diagnostics Laboratories Case Studies

Figure 13. Genetic Testing For Neurological Disorders Report Years Considered

Figure 14. Global Genetic Testing For Neurological Disorders Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Genetic Testing For Neurological Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Genetic Testing For Neurological Disorders Market Share by Region: 2024 VS 2031

Figure 17. Global Genetic Testing For Neurological Disorders Market Share by Players in 2024

Figure 18. Global Genetic Testing For Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Genetic Testing For Neurological Disorders Revenue in 2024

Figure 20. North America Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Genetic Testing For Neurological Disorders Market Share by Country (2020-2031)

Figure 22. United States Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Genetic Testing For Neurological Disorders Market Share by Country (2020-2031)

Figure 26. Germany Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Ireland Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Genetic Testing For Neurological Disorders Market Share by Region (2020-2031)

Figure 34. China Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia & New Zealand Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Genetic Testing For Neurological Disorders Market Share by Country (2020-2031)

Figure 42. Mexico Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Genetic Testing For Neurological Disorders Market Share by Country (2020-2031)

Figure 46. Israel Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Genetic Testing For Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Illumina Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 50. CENTOGENE Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 51. Victorian Clinical Genetics Services Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 52. PacBio Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 53. Mayo Clinic Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 54. Quest Diagnostics Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 55. MedGenome Labs Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 56. GeneDx Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 57. Connecticut Children's Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 58. Labcorp (Invitae/MNG Laboratories) Revenue Growth Rate in Genetic Testing For Neurological Disorders Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions